Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-09-14 5:00 pm Purchase | 13G | TRACON PHARMACEUTICALS INC TCON | Ikarian Capital LLC | 2,162,549 16.4% | 2,162,549 (New Position) | View |
| 2020-06-18 09:11 am Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | Ikarian Capital LLC | 1,592,439 7.1% | 1,592,439 (New Position) | View |
| 2020-03-23 4:31 pm Purchase | 13G | SCPHARMACEUTICALS INC SCPH | Ikarian Capital LLC | 1,073,647 5.8% | 1,073,647 (New Position) | View |
| 2020-03-23 4:28 pm Purchase | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Ikarian Capital LLC | 946,605 5.3% | 946,605 (New Position) | View |
| 2020-03-19 4:42 pm Purchase | 13G | STRONGBRIDGE BIOPHARMA PLC SHS SBBP | Ikarian Capital LLC | 3,242,787 6% | 3,242,787 (New Position) | View |
| 2020-03-09 4:44 pm Purchase | 13G | VERASTEM, INC. VSTM | Ikarian Capital LLC | 5,051,875 6.8% | 5,051,875 (New Position) | View |
| 2020-02-21 12:27 pm Purchase | 13G | ARTARA THERAPEUTICS INC TARA | Ikarian Capital LLC | 307,308 5.3% | 307,308 (New Position) | View |